Galvanize Therapeutics has raised $100 million in venture capital backing—and is making a change in leadership—to help energize its development of pulsed field ablation technology for use against ...

Pulsed field ablation has been making waves in cardiac procedures in the past few months following a series of green lights among major devicemakers looking to offer treatments for atrial fibrillation ...

The absolute rate is still below 0.5%, in line with prior ablation studies, but the issue warrants monitoring, a researcher ...

Pulsed field ablation did not have superior efficacy to radiofrequency ablation in patients with drug-resistant paroxysmal (intermittent) atrial fibrillation, according to results from a late-breaking ...

In April, we reported on a study that raised alarms for safety issues with pulsed field ablation for atrial fibrillation. In this report, we follow up on subsequent developments for this technology.

Boston Scientific shared the results during a late-breaking presentation at this year’s EHRA congress in Paris, France.